Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Nigel David Toussaint"'
Publikováno v:
Brazilian Journal of Nephrology, Vol 46, Iss 2 (2024)
Externí odkaz:
https://doaj.org/article/42501d79008945c39926f4212cac93b3
Autor:
Peter G. Kerr, Matthew J Damasiewicz, Nigel David Toussaint, Kevan R. Polkinghorne, S. Heinze, Eugenie Pedagogos, Kenneth K. Lau, Jennifer Beavis, Gavin J. Becker
Publikováno v:
Nephrology. 16:389-395
Aim: Vascular calcification is prevalent in patients with chronic kidney disease. Abdominal aortic calcification (AAC) can be detected by X-ray, although AAC is less well documented in anatomical distribution and severity compared with coronary calci
Publikováno v:
Nephrology. 16:261-268
Fibroblast growth factor 23 (FGF-23) is a recently discovered regulator of phosphate and mineral metabolism. Its main physiological function is the enhancement of renal phosphate excretion. FGF-23 levels are inversely related to renal function and in
Publikováno v:
Seminars in Dialysis. 23:43-54
Extrapolation of evidence-based management of disorders in the general population to patients with chronic kidney disease (CKD) is not always appropriate, and the prevention of bone fracture and reduction of fracture risk in CKD stages 3-5 is one exa
Autor:
Nigel David Toussaint, Boyd Josef Gimnicher Strauss, Kevan R. Polkinghorne, Peter G. Kerr, Kenneth K. Lau
Publikováno v:
Nephrology. 14:105-112
SUMMARY Background: Cardiovascular disease in dialysis patients is associated with increased vascular calcification (VC) and arterial stiffness, both inversely correlated with bone mineral density (BMD). Few studies have correlated VC in the dialysis
Autor:
Boyd Josef Gimnicher Strauss, Kenneth K. Lau, Nigel David Toussaint, Kevan R. Polkinghorne, Peter G. Kerr
Publikováno v:
Clinical Journal of the American Society of Nephrology. 4:119-127
Background and objectives: Vascular calcification (VC) contributes to increased cardiovascular (CV) disease in dialysis patients and is inversely correlated with bone mineral density (BMD). Screening for VC may determine patients at greater CV risk a
Publikováno v:
Hemodialysis International. 12:254-263
Cardiovascular (CV) disease is the most common cause of mortality in end-stage kidney disease (ESKD), and arterial stiffness, measured by pulse wave velocity (PWV), is an independent predictor of all-cause and CV mortality. B-type natriuretic peptide
Publikováno v:
NDT Plus
onlein purpura; pulmonary haemorrhage; renal failure Background Henoch-Sch¨ onlein purpura (HSP) is a systemic vasculitis predominantly occurring in prepubertal children and characterised by a purpuric rash on the lower extremities, arthralgia and a
Autor:
Nigel David Toussaint, Peter G. Kerr, Kevan R. Polkinghorne, John W M Agar, Christine A. Somerville
Publikováno v:
Hemodialysis International. 11:217-224
Benefits of dialysate with greater calcium (Ca) concentration are reported in nocturnal hemodialysis (NHD) to prevent Ca depletion and subsequent hyperparathyroidism. Studies with patients dialyzing against 1.25 mmol/L Ca baths demonstrate increases
Publikováno v:
Hemodialysis International. 10:326-337
The dialysate calcium (Ca) concentration for hemodialysis (HD) patients can be adjusted to manage more optimally the body's Ca and phosphate balance, and thus improve bone metabolism as well as reduce accelerated arteriosclerosis and cardiovascular m